| P50 | author | Andrej Perdih | Q56951306 |
| | N Minovski | Q83545744 |
| P2093 | author name string | Tom Solmajer | |
| | Marjana Novic | |
| P2860 | cites work | Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes? | Q37057393 |
| | The why and how of DNA unlinking | Q37108440 |
| | Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. | Q37392763 |
| | Validation of molecular docking programs for virtual screening against dihydropteroate synthase | Q37459651 |
| | In front of and behind the replication fork: bacterial type IIA topoisomerases. | Q37694351 |
| | Biochemical topology: applications to DNA recombination and replication | Q39501357 |
| | DNA gyrase as a drug target | Q40902870 |
| | Quinolones: structure-activity relationships and future predictions | Q40941868 |
| | Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing | Q41070926 |
| | Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach | Q46049944 |
| | Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones | Q48080383 |
| | DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities | Q50129292 |
| | Quantitative structure-activity relationship study of antitubercular fluoroquinolones. | Q51713941 |
| | Protective role of the Mycobacterium smegmatis IdeR against reactive oxygen species and isoniazid toxicity | Q57007000 |
| | Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence | Q22122411 |
| | Detailed estimation of bioinformatics prediction reliability through the Fragmented Prediction Performance Plots | Q24670617 |
| | Structural basis of gate-DNA breakage and resealing by type II topoisomerases | Q27324504 |
| | Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases | Q27655501 |
| | Crystal structure of the DNA gyrase GyrA N-terminal domain fromMycobacterium tuberculosis | Q27657595 |
| | Type IIA topoisomerase inhibition by a new class of antibacterial agents | Q27663884 |
| | Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance | Q27664216 |
| | Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase | Q27664232 |
| | SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling | Q27860614 |
| | Chemical Similarity Searching | Q28090770 |
| | Development and validation of a genetic algorithm for flexible docking | Q28236574 |
| | Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR | Q28472135 |
| | Benchmarking sets for molecular docking | Q29619637 |
| | LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters | Q31143138 |
| | Anti-tubercular drug designing by structure based screening of combinatorial libraries | Q33720784 |
| | Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment. | Q33990519 |
| | Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. | Q34214929 |
| | Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme | Q35059616 |
| | Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity | Q35059655 |
| | Fluoroquinolones: action and resistance | Q35061150 |
| | Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa | Q35115957 |
| | Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones | Q35215435 |
| | Mycobacterium avium complex pulmonary disease in patients without HIV infection | Q35859699 |
| | A novel "reactomics" approach for cancer diagnostics | Q36067925 |
| P433 | issue | 9 | |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| | in silico | Q192572 |
| P304 | page(s) | 790-801 | |
| P577 | publication date | 2012-12-19 | |
| P1433 | published in | Journal of Computational Chemistry | Q3186908 |
| P1476 | title | Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis | |
| P478 | volume | 34 | |